Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Transplant Proc ; 50(4): 1160-1166, 2018 May.
Article de Anglais | MEDLINE | ID: mdl-29731086

RÉSUMÉ

BACKGROUND: Crepidiastrum denticulatum (CD) is a well-known, traditionally consumed vegetable in Korea, which was recently reported to contain bioactive compounds with detoxification and antioxidant properties. Ischemia-reperfusion injury (IRI) is a major problem after renal transplantation. Furthermore, inflammatory responses to IRI exacerbate the resultant renal injury. In the present study, we investigated whether CD extract exhibits renoprotective effects against IR-induced acute kidney injury in mice. MATERIALS AND METHODS: Renal IRI was induced in male C57BL/6 mice by bilateral renal pedicle occlusion for 30 minutes followed by reperfusion for 48 hours. CD extract (75 mg/kg) was administered orally 5 days before IRI. RESULTS: Treatment with CD extract significantly decreased blood urea nitrogen and serum creatinine levels as well as kidney tubular injury. CD also prevented IRI-induced renal glutathione depletion and increased malondialdehyde levels. Western blotting and reverse transcriptase polymerase chain reaction indicated that CD extract significantly attenuates inducible nitric oxide synthase and toll-like receptor 2/4 protein levels 48 h after IRI. The expression of tumor necrosis factor-α and interleukin-1ß was significantly decreased in the CD extract treatment group. CONCLUSION: CD extract improved acute renal IRI through its antioxidant and anti-inflammatory effects. These findings suggest that CD extract is a potential therapeutic agent for acute ischemia-induced renal damage.


Sujet(s)
Atteinte rénale aigüe , Antioxydants/pharmacologie , Rein/effets des médicaments et des substances chimiques , Extraits de plantes/pharmacologie , Lésion d'ischémie-reperfusion , Atteinte rénale aigüe/anatomopathologie , Atteinte rénale aigüe/prévention et contrôle , Animaux , Asteraceae , Rein/anatomopathologie , Mâle , Souris , Souris de lignée C57BL , Lésion d'ischémie-reperfusion/anatomopathologie , Lésion d'ischémie-reperfusion/prévention et contrôle , République de Corée
2.
Toxicol Appl Pharmacol ; 174(2): 146-52, 2001 Jul 15.
Article de Anglais | MEDLINE | ID: mdl-11446830

RÉSUMÉ

Cruciferous vegetables contain secondary metabolites termed glucosinolates that break down to products that upregulate hepatic detoxification enzymes. We have previously shown that a mixture of four major glucosinolate breakdown products from Brussels sprouts interact to produce synergistic induction of phase II detoxification enzymes. Here we tested the hypothesis that this synergism is at the level of transcription and is due to the interaction between the oral bifunctional inducer, indole-3-carbinol (I3C), and monofunctional inducer, crambene (1-cyano 2-hydroxy 3-butene). Adult male rats were treated by gavage with either corn oil (vehicle); crambene (50 mg/kg), I3C (56 mg/kg), or a mix of crambene and I3C at the doses shown. Given orally, I3C alone and crambene with I3C caused significant induction of CYP1A activity and CYP1A1 mRNA levels, whereas crambene alone had no significant effect on CYP1A activity or mRNA levels. Crambene and I3C individually caused induction of glutathione S-transferase (GST) and quinone reductase (QR) activity. The mixture of crambene and I3C caused induction of GST and QR that was significantly greater than the sum of the induction by individual treatments. Upregulation of total GST activity was not as great as that of QR, possibly because some subunits did not show this effect. GST Ya2 mRNA showed a synergistic upregulation by crambene and I3C, while Yc1 and Yc2 showed only an additive response. We speculate that this different regulation is partly due to differences in gene sequences within the antioxidant response element and xenobiotic response element in the regulatory region of GST Ya2 compared to those within the regulatory region of the Yc1/Yc2 subunits.


Sujet(s)
Alcènes/pharmacologie , Glutathione transferase/biosynthèse , Indoles/pharmacologie , Isoenzymes/biosynthèse , Microsomes du foie/effets des médicaments et des substances chimiques , Nitriles/pharmacologie , Légumes/composition chimique , Animaux , Antioxydants/pharmacologie , Interactions médicamenteuses , Induction enzymatique/effets des médicaments et des substances chimiques , Glucosinolates/métabolisme , Glucosinolates/pharmacologie , Glutathione transferase/génétique , Inactivation métabolique/physiologie , Isoenzymes/génétique , Mâle , Microsomes du foie/enzymologie , NADPH dehydrogenase (quinone)/biosynthèse , Extraits de plantes/pharmacologie , ARN messager/biosynthèse , Rats , Régulation positive
3.
Toxicon ; 36(12): 1981-96, 1998 Dec.
Article de Anglais | MEDLINE | ID: mdl-9839682

RÉSUMÉ

Cyanobacterial toxins, especially the microcystins (MCYST), are found in eutrophied waters throughout the world. These toxins cause hepatocyte damage by inhibiting protein phosphatases 1 and 2A, resulting in hyperphosphorylation of cytoskeletal proteins. Acute intoxication of animals and humans has been reported following MCYST exposure. Okadaic acid, a marine biotoxin, has a similar mechanism of action to MCYST and has been shown to cause apoptosis, a form of programmed cell death, in a variety of cell types. In this study, primary rat hepatocytes (in suspension and monolayer culture), human fibroblasts, human endothelial cells, human epithelial cells, and rat promyelocytes were observed following treatment with MCYST for morphological and biochemical changes typical of apoptosis. Hepatocytes underwent cell membrane blebbing, cell shrinkage, organelle redistribution, and chromatin condensation as early as 30 min following MCYST application (0.8 microM). Other cell types treated with MCYST (100 microM) also showed these morphological changes, but required a longer period of treatment. DNA fragmentation and "ladder" formation occurred in most cell types exposed to MCYST. These observations demonstrate that MCYST causes apoptosis in a variety of mammalian cells.


Sujet(s)
Apoptose/effets des médicaments et des substances chimiques , Toxines bactériennes/toxicité , Cyanobactéries/physiologie , Foie/effets des médicaments et des substances chimiques , Peptides cycliques/toxicité , Animaux , Cellules cultivées , Relation dose-effet des médicaments , Endothélium/effets des médicaments et des substances chimiques , Épithélium/effets des médicaments et des substances chimiques , Fibroblastes/effets des médicaments et des substances chimiques , Humains , Leucocytes/effets des médicaments et des substances chimiques , Foie/composition chimique , Foie/ultrastructure , Mâle , Toxines de la flore et de la faune marines , Microcystines , Phosphoprotein Phosphatases/antagonistes et inhibiteurs , Rats , Rat Long-Evans
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE